Approval · Notice of Compliance 4750 · 1995
APO-SALVENT: Notice of Compliance 4750
Issued January 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4750
- Date
- January 24, 1995
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-SALVENT | 02146843 | Cancelled Post Market |
| APO-SALVENT | 02146851 | Cancelled Post Market |
Medicinal ingredients
- SALBUTAMOL SULFATE 2 MG per TAB
- SALBUTAMOL SULFATE 4 MG per TAB